IP Library Granted Patent US 8,523,847
Granted Patent B2
US 8,523,847 · App. 12/264,793 · Granted Sep 3, 2013

Reconnectable handpieces for optical energy based devices and methods for adjusting device components

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,523,847
App. No.
12/264,793
Granted
Sep 3, 2013
Kind
B2
Abstract

Handpieces which comprise characteristic data storage systems electronically storing characteristic data, devices comprising these handpieces, methods of characterizing the device components, and methods of adjusting the device components based on stored characteristic data are described. The handpieces can be repeatedly connected to, disconnected from, and reconnected to an optical energy system comprising at least one optical energy source and at least one controller by a treatment provider. When the handpieces are connected to an optical energy source and a controller, the component characteristic data is accessed and used to adjust one or more of the components in order for the components to function together within a pre-determined tolerance. Once the components are connected and adjusted, the device can be used to provide an optical energy based medical and/or cosmetic treatment to a tissue such as, for example, human skin.

Claims (34)

1. A treatment device comprising:

at least one optical energy source;

at least one controller; and

at least one handpiece, each handpiece comprising at least one optical energy delivery system configured to direct optical energy at a portion of tissue to be treated, and a first data storage system which electronically stores characteristic data relating to the handpiece;

at least one tip, each tip configured to be removably coupled with the at least one handpiece, and each tip including a pathway configured to transfer the beam from the handpiece to the portion of tissue when the tip is coupled with the handpiece;

wherein the at least one handpiece is configured to be repeatedly reconnected to the device;

the at least one optical energy source and the at least one handpiece are configured such that, when one handpiece of the at least one handpiece and the at least one energy source are operably coupled, the at least one optical energy source produces a beam of optical energy that exits an emissive end of the at least one optical energy source, enters an ingressive end of the one handpiece, passes through the at least one optical energy delivery system of the one handpiece, and exits an emissive end of the one handpiece in order to treat a portion of tissue;

the at least one controller is configured to control the at least one optical energy source and the at least one handpiece, to access the characteristic data stored in the first data storage system, and to adjust one or more functional parameters of the at least one optical energy source or one or more functional parameters of the at least one handpiece based on the characteristic data in order for the at least one handpiece to operate with the at least one optical energy source within a pre-determined tolerance; and

the at least one optical energy delivery system comprises a starburst scanner, and the controller is configured to adjust the at least one optical energy source so that a deviation of a beam path of a beam of optical energy produced by the at least one optical energy source is oriented along a line of motion of the starburst scanner and in a positive direction of motion of the starburst scanner, in order for an adjustment of a pulse delay time to compensate for the deviation of the beam path and for the at least one handpiece and the at least one optical energy source to function together within a pre-determined tolerance.

2. The device of claim 1 , wherein the at least one optical energy source comprises a laser.

3. The device of claim 1 , wherein the at least one optical energy source comprises an array of optical energy sources.

4. The device of claim 1 , wherein the at least one optical energy source comprises a set of interchangeable optical energy sources.

5. The device of claim 4 , wherein each of the optical energy sources in the set is individually characterized to determine the characteristic data.

6. The device of claim 4 , wherein each of the optical energy sources in the set is configured to deliver optical energy at a different wavelength.

7. The device of claim 4 , wherein each of the optical energy sources in the set is configured to deliver optical energy of a wavelength appropriate for treating a specific disease or condition in tissue.

8. The device of claim 4 , wherein each of the optical energy sources in the set is configured to deliver optical energy of a wavelength appropriate for treating a specific target in tissue.

9. The device of claim 1 , wherein the at least one optical energy source further comprises at least one source characteristic compensation system configured to be controlled by the at least one controller.

10. The device of claim 1 , wherein the at least one controller is configured to use characteristic data to determine at least one parameter setting that allows the at least one optical energy source and one handpiece of the at least one handpiece to function together within a pre-determined tolerance.

11. The device of claim 10 , wherein the at least one controller is configured to adjust the one or more functional parameters of the at least one optical energy source or the one or more functional parameters of the at least one handpiece to match the determined at least one parameter setting within a pre-determined tolerance.

12. The device of claim 1 , wherein the at least one controller is configured to electronically convert the characteristic data from a time-based value to a distance-based value, or the characteristic data from a distance-based value to a time-based value.

13. The device of claim 1 , wherein the at least one controller is configured to electronically collect the characteristic data.

14. The device of claim 1 , wherein the at least one controller is configured to electronically record characteristic data in the first data storage system.

15. The device of claim 1 , wherein the at least one controller is configured to electronically remove optical energy source characteristic data from combined optical energy source/handpiece characteristic data so as to convert the combined optical energy source/handpiece characteristic data to handpiece characteristic data.

16. The device of claim 1 , wherein the at least one controller is configured to electronically access the characteristic data stored in the first data storage system of the at least one handpiece, and use the characteristic data to determine at least one parameter setting that allows the at least one optical energy source and the at least one handpiece to function together within a pre-determined tolerance.

17. The device of claim 1 , wherein the at least one controller is configured to electronically collect characteristic data for the at least one optical energy source, access the characteristic data stored in the first data storage system of the at least one handpiece, and use the characteristic data collected from the at least one optical energy source and the characteristic data stored in the first data storage system to determine at least one parameter setting that allows the at least one optical energy source and the at least one handpiece to function together within a pre-determined tolerance.

18. The device of claim 1 , further comprising:

a second data storage system which stores characteristic data relating to the at least one optical energy source and which is configured to be controlled by the at least one controller.

19. The device of claim 18 , wherein the at least one controller is configured to electronically access the characteristic data stored in the second data storage system, access the handpiece characteristic data stored in the first data storage system of the at least one handpiece, and use the characteristic data relating to the at least one optical energy source or the characteristic data relating to the at least one handpiece to calculate at least one parameter setting that allows the at least one optical energy source and the at least one handpiece to function together within a predetermined tolerance.

20. The device of claim 1 , wherein the at least one optical energy source or the at least one controller are configured to be repeatedly reconnectable to the device and to be interchangeable.

21. The device of 1 , wherein the device is configured to treat the portion of tissue in a fractional manner.

22. The device of claim 1 , further comprising: at least one reconnectable transmission system for delivering the beam of optical energy from the emissive end of the optical energy source to the ingressive end of the handpiece.

23. The device of claim 22 , wherein the transmission system comprises a an optical fiber.

24. The device of claim 1 , wherein the device is configured to deliver a treatment when the at least one handpiece is in motion.

25. The device of claim 1 , wherein the device is configured to deliver a treatment when the at least one handpiece is not in motion.

Assignments (19)
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.
Reel/Frame 073637/0126 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
Reel/Frame 073654/0242 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
Reel/Frame 073654/0300 →
U.S. PATENT SECURITY AGREEMENT Recorded Jun 13, 2025
From: MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; BAUSCH HEALTH US, LLC (F/K/A VALEANT PHARMACEUTICALS NORTH AMERICA LLC); PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; BAUSCH HEALTH AMERICAS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 071564/0463 →
U.S. PATENT SECURITY AGREEMENT Recorded Jun 13, 2025
From: MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; BAUSCH HEALTH US, LLC (F/K/A VALEANT PHARMACEUTICALS NORTH AMERICA LLC); PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; BAUSCH HEALTH AMERICAS, INC.; SOLTA MEDICAL, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 071566/0200 →
SECURITY AGREEMENT (SECOND LIEN) Recorded Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
SECURITY AGREEMENT (FIRST LIEN) Recorded Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
SECURITY INTEREST Recorded Jun 13, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 060346/0705 →
SECURITY AGREEMENT Recorded Feb 10, 2022
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 059121/0001 →
SECURITY INTEREST Recorded Jun 8, 2021
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 056811/0814 →
MERGER Recorded May 14, 2021
From: RELIANT TECHNOLOGIES, LLC
To: SOLTA MEDICAL, INC.
Reel/Frame 056244/0936 →
MERGER Recorded May 12, 2021
From: RELIANT TECHNOLOGIES, INC.
To: RELIANT TECHNOLOGIES, LLC
Reel/Frame 056218/0067 →
SECURITY INTEREST Recorded Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jan 27, 2014
From: SILICON VALLEY BANK
To: RELIANT TECHNOLOGIES, LLC
Reel/Frame 032125/0810 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jan 24, 2014
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: RELIANT TECHNOLOGIES, LLC
Reel/Frame 032126/0708 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Nov 19, 2013
From: RELIANT TECHNOLOGIES, LLC
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 031674/0527 →
SECURITY INTEREST - MEZZANINE LOAN Recorded Apr 18, 2013
From: RELIANT TECHNOLOGIES, LLC
To: SILICON VALLEY BANK
Reel/Frame 030248/0256 →
SECURITY AGREEMENT Recorded Jun 16, 2009
From: RELIANT TECHNOLOGIES, LLC
To: SILICON VALLEY BANK
Reel/Frame 022824/0847 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2008
From: DEWEY, DAVID A.; PORTER, GARY
To: RELIANT TECHNOLOGIES, INC.
Reel/Frame 021957/0457 →